These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

49 related items for PubMed ID: 21041072

  • 1. Expression and vitamin D3 regulation of long-chain fatty-acid-CoA ligase 3 in human prostate cancer cells.
    Qiao S, Tuohimaa P.
    Prostaglandins Leukot Essent Fatty Acids; 2011; 84(1-2):19-23. PubMed ID: 21041072
    [Abstract] [Full Text] [Related]

  • 2. The role of long-chain fatty-acid-CoA ligase 3 in vitamin D3 and androgen control of prostate cancer LNCaP cell growth.
    Qiao S, Tuohimaa P.
    Biochem Biophys Res Commun; 2004 Jun 25; 319(2):358-68. PubMed ID: 15178414
    [Abstract] [Full Text] [Related]

  • 3. Vitamin D3 inhibits fatty acid synthase expression by stimulating the expression of long-chain fatty-acid-CoA ligase 3 in prostate cancer cells.
    Qiao S, Tuohimaa P.
    FEBS Lett; 2004 Nov 19; 577(3):451-4. PubMed ID: 15556626
    [Abstract] [Full Text] [Related]

  • 4. Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells.
    Golovko O, Nazarova N, Tuohimaa P.
    Life Sci; 2005 Jun 17; 77(5):562-77. PubMed ID: 15904673
    [Abstract] [Full Text] [Related]

  • 5. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.
    Anticancer Res; 1999 Jun 17; 19(3A):1689-97. PubMed ID: 10470102
    [Abstract] [Full Text] [Related]

  • 6. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ, Gombart AF, Kwok SH, Park S, Koeffler HP.
    Oncogene; 2000 Oct 19; 19(44):5091-7. PubMed ID: 11042697
    [Abstract] [Full Text] [Related]

  • 7. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC, Schwartz GG, Burnstein KL, Lokeshwar BL, Holick MF.
    Clin Cancer Res; 2000 Mar 19; 6(3):901-8. PubMed ID: 10741714
    [Abstract] [Full Text] [Related]

  • 8. Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1alpha,24-dihydroxyvitamin D2.
    Bauer JA, Thompson TA, Church DR, Ariazi EA, Wilding G.
    Prostate; 2003 May 15; 55(3):159-67. PubMed ID: 12692781
    [Abstract] [Full Text] [Related]

  • 9. Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
    Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, Campbell MJ.
    Oncogene; 2004 Sep 02; 23(40):6712-25. PubMed ID: 15300237
    [Abstract] [Full Text] [Related]

  • 10. Regulation of aromatase and 5alpha-reductase by 25-hydroxyvitamin D(3), 1alpha,25-dihydroxyvitamin D(3), dexamethasone and progesterone in prostate cancer cells.
    Lou YR, Murtola T, Tuohimaa P.
    J Steroid Biochem Mol Biol; 2005 Feb 02; 94(1-3):151-7. PubMed ID: 15862960
    [Abstract] [Full Text] [Related]

  • 11. Three synthetic vitamin D analogues induce prostate-specific acid phosphatase and prostate-specific antigen while inhibiting the growth of human prostate cancer cells in a vitamin D receptor-dependent fashion.
    Hedlund TE, Moffatt KA, Uskokovic MR, Miller GJ.
    Clin Cancer Res; 1997 Aug 02; 3(8):1331-8. PubMed ID: 9815816
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of prostate cancer metastasis in vivo: a comparison of 1,23-dihydroxyvitamin D (calcitriol) and EB1089.
    Lokeshwar BL, Schwartz GG, Selzer MG, Burnstein KL, Zhuang SH, Block NL, Binderup L.
    Cancer Epidemiol Biomarkers Prev; 1999 Mar 02; 8(3):241-8. PubMed ID: 10090302
    [Abstract] [Full Text] [Related]

  • 13. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy.
    Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A.
    Cancer Res; 2000 Apr 15; 60(8):2304-12. PubMed ID: 10786699
    [Abstract] [Full Text] [Related]

  • 14. Effects of 1,25(OH)2D3, 25OHD3, and EB1089 on cell growth and Vitamin D receptor mRNA and 1alpha-hydroxylase mRNA expression in primary cultures of the canine prostate.
    Kunakornsawat S, Rosol TJ, Capen CC, Omdahl JL, Leroy BE, Inpanbutr N.
    J Steroid Biochem Mol Biol; 2004 May 15; 89-90(1-5):409-12. PubMed ID: 15225811
    [Abstract] [Full Text] [Related]

  • 15. Amphiregulin is a vitamin D3 target gene in squamous cell and breast carcinoma.
    Akutsu N, Bastien Y, Lin R, Mader S, White JH.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):1051-6. PubMed ID: 11237771
    [Abstract] [Full Text] [Related]

  • 16. Regulation of cholesterol 25-hydroxylase expression by vitamin D3 metabolites in human prostate stromal cells.
    Wang JH, Tuohimaa P.
    Biochem Biophys Res Commun; 2006 Jun 30; 345(2):720-5. PubMed ID: 16696936
    [Abstract] [Full Text] [Related]

  • 17. Human prostate cancer cells: inhibition of proliferation by vitamin D analogs.
    Schwartz GG, Oeler TA, Uskoković MR, Bahnson RR.
    Anticancer Res; 1994 Jun 30; 14(3A):1077-81. PubMed ID: 8074453
    [Abstract] [Full Text] [Related]

  • 18. Human prostate cells synthesize 1,25-dihydroxyvitamin D3 from 25-hydroxyvitamin D3.
    Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF.
    Cancer Epidemiol Biomarkers Prev; 1998 May 30; 7(5):391-5. PubMed ID: 9610788
    [Abstract] [Full Text] [Related]

  • 19. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.
    Cancer Res; 1998 Aug 01; 58(15):3370-5. PubMed ID: 9699668
    [Abstract] [Full Text] [Related]

  • 20. Molecular activity of 1,25-dihydroxyvitamin D3 in primary cultures of human prostatic epithelial cells revealed by cDNA microarray analysis.
    Peehl DM, Shinghal R, Nonn L, Seto E, Krishnan AV, Brooks JD, Feldman D.
    J Steroid Biochem Mol Biol; 2004 Oct 01; 92(3):131-41. PubMed ID: 15555907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.